Large-scale testing (Phase 3)Active Not RecruitingNCT04988386
What this trial is testing
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
Who this might be right for
Amyloid Cardiomyopathy, Transthyretin-Related
Eidos Therapeutics, a BridgeBio company 389